Amicus Therapeutics, Inc. (FOLD) Ownership

$9.20

south_east
-$0.03 (-0.33%)
Day's range
$9.1
Day's range
$9.39

Amicus Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/13/2024 28.80 M $307.59 M   0.74% 9.45%
PERCEPTIVE ADVISORS LLC 11/14/2024 28.06 M $299.65 M   0.00% 9.21%
BLACKROCK FUNDING, INC. /DE 11/13/2024 26.11 M $278.82 M   100.00% 8.57%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2024 23.96 M $255.94 M   13.53% 7.87%
AVORO CAPITAL ADVISORS LLC 11/14/2024 23.18 M $247.51 M   -15.42% 7.61%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 11/08/2024 15.58 M $166.43 M   19.84% 5.11%
JPMORGAN CHASE & CO 12/26/2024 12.92 M $137.98 M   -13.12% 4.24%
STATE STREET CORP 11/14/2024 10.97 M $117.17 M   -0.42% 3.60%
REDMILE GROUP, LLC 11/14/2024 8.25 M $88.07 M   -22.17% 2.71%
PALO ALTO INVESTORS LP 11/14/2024 8.15 M $86.99 M   -9.80% 2.67%
MACQUARIE GROUP LTD 11/14/2024 6.97 M $74.44 M   -2.13% 2.29%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 6.60 M $70.50 M   1.24% 2.17%
JANUS HENDERSON GROUP PLC 11/14/2024 6.34 M $67.67 M   -52.12% 2.08%
MORGAN STANLEY 11/14/2024 4.22 M $45.02 M   -15.57% 1.38%
BANK OF AMERICA CORP /DE/ 11/14/2024 4.04 M $43.17 M   56.60% 1.33%
AMERICAN CENTURY COMPANIES INC 11/12/2024 3.90 M $41.70 M   -0.48% 1.28%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 3.65 M $38.96 M   92.06% 1.20%
CITADEL ADVISORS LLC 11/14/2024 3.63 M $38.77 M   20.33% 1.19%
FIERA CAPITAL CORP 11/01/2024 3.21 M $34.31 M   -39.16% 1.05%
GOLDMAN SACHS GROUP INC 11/14/2024 3.19 M $34.07 M   115.22% 1.05%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 11/12/2024 3.16 M $33.75 M   4.62% 1.04%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 2.67 M $28.49 M   10.01% 0.88%
INVESCO LTD. 11/12/2024 2.55 M $27.23 M   -0.12% 0.84%
NOVO HOLDINGS A/S 10/24/2024 2.50 M $26.70 M   0.00% 0.82%
BLACKSTONE INC. 11/14/2024 2.47 M $26.35 M   0.00% 0.81%
ASSENAGON ASSET MANAGEMENT S.A. 10/23/2024 2.04 M $21.76 M   141.06% 0.67%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2024 1.91 M $20.45 M   71.42% 0.63%
ABRDN PLC 10/25/2024 1.81 M $19.32 M   9.05% 0.59%
PICTET ASSET MANAGEMENT HOLDING SA 11/12/2024 1.63 M $17.43 M   -61.39% 0.53%
GRANITE INVESTMENT PARTNERS, LLC 11/12/2024 1.50 M $16.05 M   83.01% 0.49%
STEMPOINT CAPITAL LP 11/13/2024 1.48 M $15.83 M   -0.89% 0.49%
PANAGORA ASSET MANAGEMENT INC 11/13/2024 1.43 M $15.27 M   -0.11% 0.47%
HUDSON BAY CAPITAL MANAGEMENT LP 11/13/2024 1.43 M $15.22 M   33.49% 0.47%
VOYA INVESTMENT MANAGEMENT LLC 11/14/2024 1.39 M $14.84 M   7.88% 0.46%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 1.34 M $14.33 M   -3.46% 0.44%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 11/14/2024 1.28 M $13.64 M   -1.44% 0.42%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2024 1.27 M $13.53 M   100.00% 0.42%
VICTORY CAPITAL MANAGEMENT INC 11/05/2024 1.26 M $13.44 M   -44.67% 0.41%
ROCK SPRINGS CAPITAL MANAGEMENT LP 11/14/2024 1.25 M $13.35 M   2.60% 0.41%
CUBIST SYSTEMATIC STRATEGIES, LLC 11/14/2024 1.08 M $11.58 M   100.00% 0.36%
PRIMECAP MANAGEMENT CO/CA/ 11/08/2024 1.03 M $10.99 M   -2.25% 0.34%
WOODLINE PARTNERS LP 11/14/2024 1.03 M $10.98 M   100.00% 0.34%
BANK OF NEW YORK MELLON CORP 11/12/2024 1.02 M $10.84 M   -18.46% 0.33%
RICE HALL JAMES & ASSOCIATES, LLC 10/28/2024 972,138 $10.38 M   -0.02% 0.32%
NEW YORK STATE COMMON RETIREMENT FUND 10/28/2024 917,514 $9.80 M   -40.85% 0.30%
OSTERWEIS CAPITAL MANAGEMENT INC 11/14/2024 884,820 $9.45 M   28.34% 0.29%
EXODUSPOINT CAPITAL MANAGEMENT, LP 11/12/2024 817,007 $8.73 M   4.54% 0.27%
FMR LLC 11/13/2024 802,056 $8.57 M   -22.75% 0.26%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 769,300 $8.22 M   21.72% 0.25%
NEUBERGER BERMAN GROUP LLC 11/14/2024 761,730 $8.14 M   -0.01% 0.25%

Amicus Therapeutics, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of FOLD shares?

During the previous two years, 385 institutional investors and hedge funds held shares of Amicus Therapeutics, Inc.. The most heavily invested institutionals were:

Sage Capital Advisors,llc: 0

CVA Family Office, LLC: 0

VANGUARD GROUP INC: 28.8 M

PERCEPTIVE ADVISORS LLC: 28.06 M

BlackRock Funding, Inc. /DE: 26.11 M

WELLINGTON MANAGEMENT GROUP LLP: 23.96 M

What percentage of Amicus Therapeutics, Inc. stock is owned by institutional investors?

100.70% of Amicus Therapeutics, Inc. stock is owned by institutional investors.

How much institutional buying is happening at FOLD ?

Institutional investors have bought a total of 372.13 M shares in the last 24 months. This purchase volume represents approximately $3.42 B in transactions.